• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年抑郁症患者维持治疗中去甲替林与苯乙肼的安慰剂对照比较。

A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients.

作者信息

Georgotas A, McCue R E, Cooper T B

机构信息

Depression Studies Program, New York University School of Medicine, New York.

出版信息

Arch Gen Psychiatry. 1989 Sep;46(9):783-6. doi: 10.1001/archpsyc.1989.01810090025004.

DOI:10.1001/archpsyc.1989.01810090025004
PMID:2673129
Abstract

Fifty-one elderly depressed outpatients who had responded to antidepressants and completed continuation therapy were observed under double-blind conditions for 1 year. Twenty-three had been switched to placebo, while 13 and 15 took nortriptyline hydrochloride and phenelzine sulfate, respectively. Patients administered phenelzine did significantly better with 13.3% recurrences than patients administered either nortriptyline (53.8% recurrences) or placebo (65.2% recurrences). In addition, patients who had higher Hamilton scores and who had an earlier age of onset of the first depressive episode were significantly more likely to have recurrences.

摘要

51名对抗抑郁药有反应并完成持续治疗的老年抑郁症门诊患者在双盲条件下观察了1年。23名患者被换用安慰剂,而13名和15名患者分别服用盐酸去甲替林和硫酸苯乙肼。服用苯乙肼的患者复发率为13.3%,明显低于服用去甲替林(复发率53.8%)或安慰剂(复发率65.2%)的患者。此外,汉密尔顿评分较高且首次抑郁发作发病年龄较早的患者复发的可能性明显更大。

相似文献

1
A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients.老年抑郁症患者维持治疗中去甲替林与苯乙肼的安慰剂对照比较。
Arch Gen Psychiatry. 1989 Sep;46(9):783-6. doi: 10.1001/archpsyc.1989.01810090025004.
2
How effective and safe is continuation therapy in elderly depressed patients? Factors affecting relapse rate.延续治疗对老年抑郁症患者的有效性和安全性如何?影响复发率的因素。
Arch Gen Psychiatry. 1988 Oct;45(10):929-32. doi: 10.1001/archpsyc.1988.01800340057008.
3
A placebo-controlled comparison of the effect of nortriptyline and phenelzine on orthostatic hypotension in elderly depressed patients.
J Clin Psychopharmacol. 1987 Dec;7(6):413-6.
4
Factors affecting the delay of antidepressant effect in responders to nortriptyline and phenelzine.
Psychiatry Res. 1989 Apr;28(1):1-9. doi: 10.1016/0165-1781(89)90192-3.
5
Phenelzine for chronic depression: a study of continuation treatment.苯乙肼治疗慢性抑郁症:延续治疗研究
J Clin Psychiatry. 1986 Jul;47(7):346-9.
6
Relapse of depressed patients after effective continuation therapy.抑郁症患者在有效维持治疗后的复发情况。
J Affect Disord. 1989 Sep-Oct;17(2):159-64. doi: 10.1016/0165-0327(89)90038-4.
7
The usefulness of DST in predicting response to antidepressants: a placebo-controlled study.地塞米松抑制试验在预测抗抑郁药反应中的效用:一项安慰剂对照研究。
J Affect Disord. 1986 Jul-Aug;11(1):21-8. doi: 10.1016/0165-0327(86)90055-8.
8
Combined pharmacotherapy and psychotherapy in the acute and continuation treatment of elderly patients with recurrent major depression: a preliminary report.联合药物治疗与心理治疗用于老年复发性重度抑郁症患者的急性期和延续期治疗:初步报告
Am J Psychiatry. 1992 Dec;149(12):1687-92. doi: 10.1176/ajp.149.12.1687.
9
Response of depressive symptoms to nortriptyline, phenelzine and placebo.抑郁症状对去甲替林、苯乙肼和安慰剂的反应。
Br J Psychiatry. 1987 Jul;151:102-6. doi: 10.1192/bjp.151.1.102.
10
Prediction of response to nortriptyline and phenelzine by platelet MAO activity.
Am J Psychiatry. 1987 Mar;144(3):338-40. doi: 10.1176/ajp.144.3.338.

引用本文的文献

1
Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults.成人抑郁和焦虑障碍中长效抗抑郁药停药与继续使用的方法。
Cochrane Database Syst Rev. 2021 Apr 15;4(4):CD013495. doi: 10.1002/14651858.CD013495.pub2.
2
Potential Roles of microRNAs in the Regulation of Monoamine Oxidase A in the Brain.微小RNA在大脑中对单胺氧化酶A调控的潜在作用
Front Mol Neurosci. 2018 Sep 14;11:339. doi: 10.3389/fnmol.2018.00339. eCollection 2018.
3
Predicting relapse with individual residual symptoms in major depressive disorder: a reanalysis of the STAR*D data.
利用重度抑郁症个体残留症状预测复发:STAR*D数据的再分析
Psychopharmacology (Berl). 2017 Aug;234(16):2453-2461. doi: 10.1007/s00213-017-4634-5. Epub 2017 May 3.
4
Continuation and maintenance treatments for depression in older people.老年人抑郁症的延续性和维持性治疗。
Cochrane Database Syst Rev. 2016 Sep 9;9(9):CD006727. doi: 10.1002/14651858.CD006727.pub3.
5
Prevention of Relapse and Recurrence in Adults with Major Depressive Disorder: Systematic Review and Meta-Analyses of Controlled Trials.成人重度抑郁症复发的预防:对照试验的系统评价与荟萃分析
Int J Neuropsychopharmacol. 2015 Jul 7;19(2):pyv076. doi: 10.1093/ijnp/pyv076.
6
Current place of monoamine oxidase inhibitors in the treatment of depression.单胺氧化酶抑制剂在抑郁症治疗中的现状。
CNS Drugs. 2013 Oct;27(10):789-97. doi: 10.1007/s40263-013-0097-3.
7
Addressing both depression and pain in late life: the methodology of the ADAPT study.解决老年人的抑郁和疼痛问题:ADAPT 研究的方法学。
Pain Med. 2012 Mar;13(3):405-18. doi: 10.1111/j.1526-4637.2011.01322.x. Epub 2012 Feb 7.
8
Blue again: perturbational effects of antidepressants suggest monoaminergic homeostasis in major depression.再次呈现蓝色:抗抑郁药的扰动效应表明重性抑郁症中单胺能稳态。
Front Psychol. 2011 Jul 7;2:159. doi: 10.3389/fpsyg.2011.00159. eCollection 2011.
9
Continuation treatment of major depressive disorder: is there a case for duloxetine?重度抑郁症的持续治疗:度洛西汀是否适用?
Drug Des Devel Ther. 2010 Feb 18;4:19-31. doi: 10.2147/dddt.s4358.
10
Use of antidepressants in late-life depression.抗抑郁药在老年抑郁症中的应用。
Drugs Aging. 2008;25(10):841-53. doi: 10.2165/00002512-200825100-00003.